Comprehensive solutions
Choose 5′RACE + UMI or multiplex PCR with RNA or DNA inputs to match the sample type and study goal.
A flexible and robust NGS platform for comprehensive adaptive immune repertoire profiling—from library preparation to data analysis.
ImmuHub® supports repertoire discovery, clonal tracking and longitudinal immune monitoring across research areas.
Choose 5′RACE + UMI or multiplex PCR with RNA or DNA inputs to match the sample type and study goal.
Optimized library construction and molecular barcode workflows help reduce PCR and sequencing-derived errors.
Biomarker discovery, disease monitoring, immunotherapy response, vaccine studies and antibody research.
Experimental design, sequencing strategy and bioinformatics interpretation from an experienced immunology team.
Cells, sorted T/B cells, RNA, DNA, fresh/frozen tissues and FFPE specimens.
Full-length V(D)J or targeted CDR3 workflows.
Compatible library designs for major high-throughput sequencing platforms.
Clonotypes, V(D)J usage, diversity, shared clones, tracking, SHM, isotypes and custom analyses.
Each T cell carries a distinctive receptor generated through V(D)J recombination. Repertoire sequencing enables systematic analysis of clonality, diversity, CDR3 composition and longitudinal clonal dynamics.
Applications include tumor immunology, autoimmune disease, infection, transplantation, vaccines and cell therapy.

Profile immunoglobulin heavy and light chains, clonal architecture, isotype usage and somatic hypermutation to study B-cell responses and antibody maturation.
Measure diversity, clonality, CDR3 features and V(D)J gene usage across tissues, cohorts or time points.
Follow expanded or contracted clones before and after checkpoint blockade, CAR-T, TCR-T or other treatments.
Identify convergent receptor signatures and characterize adaptive immune responses after infection or immunization.
Combine repertoire features with clinical or multi-omic data to discover response-associated immune signatures.
Recover full-length variable regions, prioritize expanded B-cell lineages and support recombinant antibody development.
Use clonotype tracking in hematologic malignancy research within appropriately validated study designs.
The ImmuHub® publication page currently lists 63 peer-reviewed papers with a cumulative impact factor of 857.0.
Integrated TRB, TRG and IGH profiling across peripheral blood and pleural effusion.
Evaluated the prognostic value of post-CAR-T NGS-MRD in B-ALL.
Characterized BCR repertoire features and shared motifs across disease severity groups.